CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
CRYO CELL INTERNATIONAL INC
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026
$4.65+0.23 (+5.20%)
Close on Oct 19, 2026
- Market cap
- $37.50M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.10 (+2.20%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
CRYO CELL INTERNATIONAL INC saw revenue fall 2.0% to $31.13M over the twelve months to Aug 31, 2026. Operating income fell 95.6% to $189.42K, moving the operating margin from 13.6% to 0.6%. Free cash flow was $4.65M, down 24.8% from a year earlier.
Revenue
$31.13M
-2.0% vs. a year earlier
Operating income
$189.42K
-95.6% vs. a year earlier
Free cash flow
$4.65M
-24.8% vs. a year earlier
EPS, diluted
-$0.24
TTM Q3 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Aug 31, 2026
Valuation
- Market cap
- $37.50M
- P/E ratio
- –
- Price to sales
- 1.20
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 12.40%
Fundamentals
- Revenue
- $31.13M
- Net income
- -$1.95M
- EPS, diluted
- -$0.24
- Free cash flow
- $4.65M
- Book value per share
- -$2.03
- Diluted shares
- 8M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$31.13M-2.0% YoY
Gross profit
$24.45M-0.1% YoY
Operating income
$189.42K-95.6% YoY
Net income
-$1.95M
EPS, diluted
-$0.24
Free cash flow
$4.65M-24.8% YoY
Reported periodTrailing twelve months